Exebacase in Addition to Daptomycin against MRSA
Author(s) -
Razieh Kebriaei,
Kyle Stamper,
Katherine L. Lev,
Taylor Morrisette,
Jacinda C. AbdulMutakabbir,
Raymond Schuch,
Dario Lehoux,
Michael J. Rybak
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00128-21
Subject(s) - daptomycin , staphylococcus aureus , methicillin resistant staphylococcus aureus , microbiology and biotechnology , pharmacodynamics , ex vivo , in vivo , lytic cycle , staphylococcal infections , pharmacokinetics , antibiotics , pharmacology , chemistry , medicine , vancomycin , biology , bacteria , virology , virus , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom